Trial Profile
Clinical Trials Insight: 700012640
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Mar 2006
Price :
$35
*
At a glance
- Drugs Omadacycline (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections; Nosocomial infections; Skin and soft tissue infections
- Focus Adverse reactions
- Sponsors Merck & Co; Paratek Pharmaceuticals
- 13 Mar 2006 New trial record.